7.95
price up icon3.79%   0.29
after-market After Hours: 8.00 0.05 +0.63%
loading

Elicio Therapeutics Inc Stock (ELTX) Forecast

The Elicio Therapeutics Inc (ELTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.0881, representing a -10.84% decrease from the current price of $7.95. The highest analyst price target is $7.9631, and the lowest is $6.2132.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELTX Price Target
Average 7.348 (-7.57% Downside)
loading

Is Elicio Therapeutics Inc (ELTX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 50.03 Neutral
STOCH(9,6) 25.07 Neutral
STOCHRSI(14) 36.53 Neutral
MACD(12,26) 0.0251 Sell
ADX(14) 17.42 Neutral
William %R -67.50 Neutral
CCI(14) -79.78 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
8.00
Sell
7.9595
Sell
MA20
8.0505
Sell
8.0149
Sell
MA50
7.547
Buy
7.5138
Buy
MA100
6.2481
Buy
6.7712
Buy
MA200
5.748
Buy
6.2936
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, ELTX could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ELTX, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 50.03 indicates that ELTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 25.07 indicates that ELTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 36.53 indicates that ELTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 17.42 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -79.78 indicates that ELTX is still oversold but not to an extreme extent.

Long-term ELTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Elicio Therapeutics Inc financial reports and earnings history, Elicio Therapeutics Inc (ELTX) stock could reach $12.43 by 2030, $15.46 by 2040 and $16.35 by 2050. See the projected annual prices until 2050 of the Elicio Therapeutics Inc stock below:

  • Elicio Therapeutics Inc (ELTX) is expected to reach an average price of $12.07 in 2035, with a high prediction of $13.73 and a low estimate of $11.28. This indicates an $51.82% rise from the last recorded price of $7.95.
  • Elicio Therapeutics Inc (ELTX) stock is projected to chart a bullish course in 2040, with an average price target of $10.13, representing an $27.48% surge from its current level. The forecast ranges from a conservative $9.7444 to a sky-high $15.46.
  • Our analysts predict Elicio Therapeutics Inc (ELTX) to jump 78.67% by 2045, soaring from $13.80 to an average price of $14.20, potentially reaching $16.44. While $13.80 is the low estimate, the potential upside is significant.
  • Elicio Therapeutics Inc (ELTX) stock is expected to climb by 2050, reaching an average of $12.55, a $57.92% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.35 and $10.98, respectively, highlighting the market's uncertainty.

Elicio Therapeutics Inc Stock (ELTX) Year by Year Forecast

Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2025

Elicio Therapeutics Inc Stock (ELTX) is expected to reach an average price of $7.2316 in 2025, with a high prediction of $11.04 and a low estimate of $3.4277. This indicates an -9.04% fall from the last recorded price of $7.95.
Month Average Low High Change from today's price
April, 2025 $6.3734 $6.2132 $7.9631 -19.83%
May, 2025 $6.4546 $5.6537 $7.4646 -18.81%
June, 2025 $7.5658 $5.9252 $11.04 -4.83%
July, 2025 $4.8674 $3.5168 $8.5861 -38.78%
August, 2025 $4.5286 $3.4277 $4.968 -43.04%
September, 2025 $7.2898 $4.3489 $7.5898 -8.30%
October, 2025 $9.4614 $6.7701 $10.91 +19.01%
November, 2025 $8.4505 $8.0455 $10.69 +6.30%
December, 2025 $6.7528 $6.7528 $10.32 -15.06%

Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2026

The predicted value for Elicio Therapeutics Inc (ELTX) in 2026 is set at an average of $7.5813. Estimates vary from a peak of $11.50 to a trough of $3.6615, indicating an -4.64% surge from the present price of $7.95.
Month Average Low High Change from today's price
January, 2026 $6.5646 $6.4447 $8.1946 -17.43%
February, 2026 $6.5864 $5.8855 $7.1955 -17.15%
March, 2026 $9.0383 $6.1578 $11.27 +13.69%
April, 2026 $5.1006 $3.7501 $9.1287 -35.84%
May, 2026 $4.8024 $3.6615 $5.351 -39.59%
June, 2026 $5.7043 $4.3129 $6.4243 -28.25%
July, 2026 $9.1066 $6.1047 $11.14 +14.55%
August, 2026 $9.54 $9.047 $10.61 +20.00%
September, 2026 $7.4431 $7.1131 $10.92 -6.38%
October, 2026 $7.4355 $6.9837 $8.4237 -6.47%
November, 2026 $7.078 $6.1174 $8.4261 -10.97%
December, 2026 $9.271 $6.3904 $11.50 +16.62%

Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Elicio Therapeutics Inc (ELTX) is $7.8146, with a high forecast of $11.73 and a low forecast of $3.8953. This indicates an -1.70% decrease from the last price of $7.95.
Month Average Low High Change from today's price
January, 2027 $5.5535 $3.9835 $9.3617 -30.14%
February, 2027 $5.096 $3.8953 $5.8841 -35.90%
March, 2027 $5.939 $4.5472 $6.659 -25.30%
April, 2027 $10.79 $6.3396 $10.84 +35.74%
May, 2027 $10.15 $8.9221 $11.38 +27.68%
June, 2027 $8.6531 $8.0631 $11.15 +8.84%
July, 2027 $7.8761 $7.2146 $8.6546 -0.93%
August, 2027 $7.1592 $6.3492 $8.6577 -9.95%
September, 2027 $7.613 $6.585 $8.4123 -4.24%
October, 2027 $5.8561 $5.4361 $11.73 -26.34%
November, 2027 $5.3492 $4.1292 $6.1176 -32.71%
December, 2027 $6.093 $4.7815 $6.323 -23.36%

Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2028

In 2028, Elicio Therapeutics Inc (ELTX) is projected to reach an average price of $8.1648, with a high projection of $11.97 and a low estimate of $4.363. This indicates an +2.70% rise from the last price of $7.95.
Month Average Low High Change from today's price
January, 2028 $10.03 $5.8048 $10.20 +26.11%
February, 2028 $10.38 $9.1576 $11.61 +30.56%
March, 2028 $9.8328 $8.7359 $11.38 +23.68%
April, 2028 $7.7864 $7.4455 $10.10 -2.06%
May, 2028 $7.391 $6.581 $8.8892 -7.03%
June, 2028 $7.9547 $6.817 $8.6447 +0.06%
July, 2028 $6.6384 $6.2484 $11.97 -16.50%
August, 2028 $5.583 $4.363 $7.0793 -29.77%
September, 2028 $5.5567 $5.0158 $5.9039 -30.10%
October, 2028 $9.0104 $5.3755 $9.2104 +13.34%
November, 2028 $10.61 $7.9333 $11.85 +33.52%
December, 2028 $9.4221 $8.9661 $11.61 +18.52%

Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2029

The 2029 price forecast for Elicio Therapeutics Inc Stock (ELTX) is $8.3981 on average, with a high prediction of $12.20 and a low estimate of $4.5968. This represents an +5.64% increase from the previous price of $7.95.
Month Average Low High Change from today's price
January, 2029 $8.0175 $7.6764 $11.24 +0.85%
February, 2029 $7.5318 $7.3708 $9.1207 -5.26%
March, 2029 $7.6161 $6.8129 $8.6261 -4.20%
April, 2029 $8.7304 $7.0883 $12.20 +9.82%
May, 2029 $6.0358 $4.6836 $9.7515 -24.08%
June, 2029 $5.7001 $4.5968 $6.1379 -28.30%
July, 2029 $8.4644 $5.5211 $8.7644 +6.47%
August, 2029 $10.64 $7.9454 $12.09 +33.83%
September, 2029 $9.6012 $9.1962 $11.84 +20.77%
October, 2029 $7.9074 $7.9074 $11.47 -0.54%
November, 2029 $7.7223 $7.6024 $9.3523 -2.86%
December, 2029 $7.7472 $7.0447 $8.3547 -2.55%

Elicio Therapeutics Inc Stock (ELTX) Price Forecast for 2030

Elicio Therapeutics Inc Stock (ELTX) is expected to reach an average price of $8.7478 in 2030, with a high forecast of $12.66 and a low forecast of $4.8307. This signifies an +10.03% surge from the last price of $7.95.
Month Average Low High Change from today's price
January, 2030 $8.9633 $7.3209 $12.43 +12.75%
February, 2030 $6.2682 $4.917 $9.9845 -21.15%
March, 2030 $5.9731 $4.8307 $6.5195 -24.87%
April, 2030 $6.878 $5.4844 $7.598 -13.48%
May, 2030 $10.28 $7.2793 $12.32 +29.36%
June, 2030 $10.69 $10.23 $11.79 +34.47%
July, 2030 $8.5969 $8.2669 $12.07 +8.14%
August, 2030 $8.5924 $8.1383 $9.5783 +8.08%
September, 2030 $8.238 $7.2766 $9.5838 +3.62%
October, 2030 $10.43 $7.5535 $12.66 +31.26%
November, 2030 $6.7204 $5.1504 $10.53 -15.47%
December, 2030 $6.2659 $5.0645 $7.0518 -21.18%
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
Cap:     |  Volume (24h):